DIAGNOSTICS AND TREATMENT OF MITRAL VALVE PROLAPSE
https://doi.org/10.20996/1819-6446-2010-6-4-539-542
Abstract
The mitral valve prolapse (MVP) is one of the most inconsistent diagnose. In the most cases patients with MVP have the good long-term prognosis, and therapy is aimed at reduction in psychovegetative dysfunction. Careful follow-up and timely cardiosurgical correction should be performed, if necessary, in patients with classical MPV. The choice method in these cases is the mitral valve plasty.
About the Authors
D. A. Kuzhel
Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky,
Institute of ambulatory care
Russian Federation
Russian Federation
Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660093
Aerovokzalnaya ul. 19, Krasnoyarsk, 660022
G. V. Matyushin
Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky,
Institute of ambulatory care
Russian Federation
Russian Federation
Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660093
Aerovokzalnaya ul. 19, Krasnoyarsk, 660022
E. A. Savchenko
Krasnoyarsk State Medical University named after Prof. V.F. Voyno-Yasenetsky,
Institute of ambulatory care
Russian Federation
Russian Federation
Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660093
Aerovokzalnaya ul. 19, Krasnoyarsk, 660022
References
1. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow R.O., Carabello B.A., Kanu C. et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/AmericanHeartAssociation Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114(5):e84-231.
2. Barlow J.B., Pocock W.A. The significance of late systolic murmurs and mid-late systolic clicks. Md State Med J 1963;12:76-7.
3. Criley J.M., Lewis K.B., Humphries J.O., Ross R.S. Prolapse of the mitral valve: clinical and cine-angiocardiographic findings. Br Heart J 1966;28(4):488–96.
4. Pellerin D., Brecker S., Veyrat C. Degenerative mitral valve disease with emphasis on mitral valve prolapse. Heart 2002;88 Suppl 4:iv20-8.
5. Freed L.A., Levy D., Levine R.A. et al. Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med 1999;341(1):1-7.
6. Сторожаков Г.И., Верещагина Г.С., Малышева Н.В. Стратификация риска и выбор клинической тактики у пациентов с пролапсом митрального клапана. Сердечная недостаточность 2001;2(6): 23-31.
7. St John Sutton M., Weyman A.E. Mitral valve prolapse prevalence and complications: an ongoing dialogue. Circulation 2002;106(11):1305-7.
8. Фейгенбаум Х. Эхокардиография. 5-е издание. М.: Видар; 1999.
9. Шиллер Н., Осипов М.А. Клиническая эхокардиография. 2-е издание. М.: Практика; 2005.
10. Avierinos J.F., Gersh B.J., Melton L.J. 3rd et al. Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002;106(11):1355-61.
11. Wilcken D.E., Hickey A.J. Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgery. Circulation 1988;78(1):10-4.
12. Devereux R.B., Jones E.C., Roman M.J. et al. Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians:the StrongHeart Study.Am J Med 2001;111(9):679–85.
13. Fann J.I., Ingels N.B., Jr., Miller D.C. Pathophysiology of Mitral Valve Disease. In: Cohn L.H., Edmunds L.H.Jr, eds. Cardiac Surgery in the Adult, 2nd ed. New York: McGraw-Hill; 2003. p. 901-931.
14. Devereux R.B.,Hawkins I., Kramer-Fox R. et al. Complications of mitral valve prolapse. Disproportionate occurrence in men and older patients. Am J Med 1986;81(5):751-8.
15. Ling L.H., Enriquez-Sarano M., Seward J.B. et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996;335(19):1417-23.
16. Horstkotte D., Follath F., Gutschik E. et al. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 2004;25(3):267-76.
17. Barnett H.J., Boughner D.R., Taylor D.W. et al. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med 1980;302(3):139–44.
18. Gilon D., Buonanno F.S.,Joffe M.M. et al. Lack of evidence of an association between mitral-valve prolapse and stroke in young patients. N Engl J Med 1999;341(1):8-13.
19. Martini B., Basso C., Thiene G. Sudden death in mitral valve prolapse with Holter monitoring-documented ventricularfibrillation: evidence of coexisting arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol 1995;49(3):274-8.
20. Puddu P.E., Pasternac A., Tubau J.F. et al. QT interval prolongation and increased plasma catecholamine levels in patients with mitral valve prolapse. Am Heart J 1983;105(3):422-8.
21. Vohra J., Sathe S., Warren R. et al. Malignant ventricular arrhythmias in patients with mitral valve prolapse and mild mitral regurgitation. Pacing Clin Electrophysiol 1993;16(3 Pt 1):387-93.
22. Otto C.M. Timing of surgery in mitral regurgitation. Heart 2003;89(1):100-5.
23. Alfieri O., Maisano F., De Bonis M. et al. The double orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122(4):674-81.
24. Braunberger E., Deloche A., Berrebi A. et al. Very long-term results (more than 20 years) of valve repair with Carpentier’s techniques in nonrheumatic mitral valve insufficiency. Circulation 2001;104(12 Suppl 1):I8–11.
25. David T.E., Ivanov J., Armstrong S., et al. Late outcomes of mitral valve repair for floppy valves: implications for asymptomatic patients. J Thorac Cardiovasc Surg 2003;125(5):1143–52.
26. Gillinov A.M., Cosgrove D.M., Blackstone E.H. et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg 1998;116(5):734-43.
Review
For citations:
Kuzhel D.A., Matyushin G.V., Savchenko E.A. DIAGNOSTICS AND TREATMENT OF MITRAL VALVE PROLAPSE. Rational Pharmacotherapy in Cardiology. 2010;6(4):539-542. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-4-539-542
Views:
748
Email this article 